Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer.

Saved in:
Bibliographic Details
Title: Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer.
Authors: Wirth LJ; Massachusetts General Hospital Cancer Center, Boston, MA., Kohno T; National Cancer Research Institute, Tokyo, Japan., Udagawa H; National Cancer Center Hospital East, Kashiwa, Japan., Matsumoto S; National Cancer Center Hospital East, Kashiwa, Japan., Ishii G; National Cancer Center Hospital East, Kashiwa, Japan., Ebata K; Loxo Oncology, Stamford, CT., Tuch BB; Loxo Oncology, Stamford, CT., Zhu EY; Loxo Oncology, Stamford, CT., Nguyen M; Loxo Oncology, Stamford, CT., Smith S; Loxo Oncology, Stamford, CT., Hanson LM; Array BioPharma, Boulder, CO., Burkard MR; Array BioPharma, Boulder, CO., Cable L; Loxo Oncology, Stamford, CT., Blake JF; Loxo Oncology, Stamford, CT., Condroski KR; National Cancer Center Hospital East, Kashiwa, Japan., Brandhuber BJ; National Cancer Center Hospital East, Kashiwa, Japan., Andrews S; National Cancer Center Hospital East, Kashiwa, Japan., Rothenberg SM; Loxo Oncology, Stamford, CT., Goto K; National Cancer Center Hospital East, Kashiwa, Japan.
Source: JCO precision oncology [JCO Precis Oncol] 2019 Sep 11; Vol. 3. Date of Electronic Publication: 2019 Sep 11 (Print Publication: 2019).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: eCollection Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO.19.00189